NEUTRALIZATION ASSAY FOR L2 SERA

Patricia Day and Susana Pang

John Schiller’s group

Lab of Cellular Oncology, NCI/NIH

 

Citation:  Clin Vaccine Immunol. 2012 Jul;19(7):1075-82.  A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.

Day PMPang YYKines RCThompson CDLowy DRSchiller JT.

 

Typical schedule:

 

Friday:

split CHO-Δfurin cells 1x106cells/17 mls in T75 (enough for 3x 96 plates)

 

Monday:

plate MCF10A cells 2x104/well 96 well plate 100 µl volume/well (plate in am)

split pgsa-745 cells to be ready on Wednesday

 

Tuesday:

make ECM from 10A cells:         wash cells with PBS 3x

                                                add 50 µl pre-warmed lysis buffer/well

                                                incubate 5 minutes, confirm lysis microscopically

                                                gently add 100 µl PBS (add to side walls)

                                                remove 100 µl liquid

                                                gently add 100 µl PBS

                                                remove 100 µl liquid

                                                gently add 100 µl PBS

                                                remove all liquid

                                                rinse wells 2x with 100 µl PBS

                                                leave plate in PBS until ready for next step

 

harvest supernatant from CHO-Δfurin cells

pellet cells and decant sup to new tube

 

make dilutions of virus in L2 assay medium calculate to add 50 µl/well virus (see notes following)

 

remove PBS from plate 

 

add 70 µl/well of Δfurin sup with Heparin (add heparin to final concentration of 5µg/ml, note that after adding 50µl of virus, the final volume will be 120µl)

 

add virus dilution, leave one row with no virus for background control

 

incubate at 37°C overnight

 

Wednesday:

remove medium/virus mix 

wash with PBS 2X.  leave on PBS until ready for next step

 

make antibody titrations in L2 assay media, need 100µl/well

remove last wash and add antibody (or media for infection controls)

incubate at 37°C 6 hours

 

harvest pgsa-745 cells with 0.05% trypsin

pellet cells and resuspend in L2 assay media

 

do not remove antibody

 

 

add pgsa-745 cells 50 µl/well at concentration of 1.6x105/ml (8x103/well)

incubate 37°C 2 days

 

Friday

rinse with PBS, add 50 µl/well .05% trypsin, add 150 µl/well FACS buffer

read GFP fluorescence on flow cytometer

 

Notes:  

•Can store 10A ECM at -80°C w/ and w/o 100 µl PBS or 4°C with 100 µl PBS, 0.1% NaN3  

for at least 2 months.

•CHO-Δfurin supernatant is good for at least 3 days up to 7 days.

 

 

 

 

 

MCF10A cells (ATCC cat# CRL-10317)

            media:  DMEM/F12

                        5% horse serum (Sigma Cat# H1138, Lot# 11G413)

                        glutamine

                        pen/strep

                        500 µg/ml hydrocortisone

                        10 µg/ml insulin

                        20 ng/ml EGF

 

CHO-Δfurin cells (NCI  Cell Repository)

& pgsa-745 cells (ATCC cat# CRL-2242)

            media:  DMEM

                        10% FBS

                        200 µM proline

                             1% Pen Strep

 

L2 assay medium

              media:   DMEM

                         10% FBS

                         200 µM proline

                              1% Antibiotic/Antimycotic

 

H-4784 heparin (Sigma)

 

Lysis buffer:      PBS

                        0.5% v/v Triton x-100

                        20 mM NH4OH

                        store at 4oC

 

FACS buffer:     PBS

                        2% FBS

                        0.1% NaN3

 

 

Pseudovirus:    make “ripcord” method pseudovirus with packaged fwB plasmid

titer pseudovirus in assay prior to testing neutralization

the starting concentration should give ~60% infection

at present we assay 3 dilutions of virus (3-fold dilutions starting from 60% infection) 

for our HPV16 stock the starting concentration is 13 ng L1/well 


typical plate setup

row A:             media/cells only

row B:              virus/no ab/cells

rows C-H:          virus/serial dilution of antibody/cells

column 1:         no virus/ab dilutions/cells

columns 2-12:   virus dilutions or different viruses

 

 

 

 

 

Last updated by Buck, Christopher (NIH/NCI) [E] on Oct 21, 2018